Navigation Links
Osseon® Announces Commercial Release of Osseoflex®SN (Steerable Needle)
Date:9/1/2011

SANTA ROSA, Calif., Sept. 1, 2011 /PRNewswire/ -- Today, Osseon® Therapeutics, Inc. launched the Osseoflex®SN (steerable needle). Osseoflex SN is the newest in Osseon's suite of minimally invasive products for treatment of spinal compression fractures.

(Photo:  http://photos.prnewswire.com/prnh/20110901/SF61461)

The Osseoflex SN allows direct unipedicular access to the entire vertebral body. The Osseoplasty™ procedure offers unparalleled flexibility and control for percutaneous vertebral augmentation, cement delivery, and fracture stabilization, resulting in significant pain relief for most patients within the same day.

"Osseoflex SN is the next generation of steerable, minimally invasive cement delivery devices for the treatment of osteoporosis and related bone diseases and injuries. Our technology for vertebral compression fracture treatment offers increased precision, less operating time for physicians and decreased risk for patients," said John Stalcup, Ph.D., Osseon's CEO and President.

Osseon Therapeutics currently markets Osseoflex®SN (steerable needle), Osseoperm® (bone cement), Osseoflex®DR (steerable bone drill), Osseoflex®BT (steerable bone tamp), and Osseoflex®Access (bone access kit). Together, Osseon's suite of products provides groundbreaking biomedical devices for physicians who treat vertebral compression fractures due to osteoporosis, myeloma, and acute osteo-traumatic injuries.

About Osseon

Osseon Therapeutics, Inc. focuses on bringing to market alternative minimally invasive treatments for degenerative bone and joint disease. Headquartered in Santa Rosa, CA, the company's groundbreaking technology and delivery systems provide efficacy and safety competitive with all other commercial solutions, while delivering superior efficiency and cost. By improving the treatment of compression fractures within the entire thoracic and lumbar spine, Osseon offers alternative solutions to symptomatic patients as well as to the physicians and medical facilities that treat them. Osseon's products have received both FDA clearance and the CE Mark for product distribution in the United States and the European Union.

For more information, visit our website at www.osseon.com.


'/>"/>
SOURCE Osseon Therapeutics, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Osseon® Therapeutics Names Gary Coughlen, CPA as New Chief Financial Officer
2. Osseon® Therapeutics Introduces New Osseoflex® DR Steerable Bone Drill
3. PTCB Board of Governors Announces Executive Director/CEO Murer Corrigan to Leave Organization
4. Hill-Rom Announces Fourth Quarter 2011 Dividend
5. Volcano Corporation Announces Presentations at Upcoming Investor Conferences
6. Sequenom Announces Participation at William Blair and Company 5th Annual Emerging Growth Stock Conference
7. Delcath Announces Top-Line Results From Metastatic Colorectal Cohort in Phase II Trial of Chemosaturation System
8. Concord Medical Services Announces the Appointment of Mr. Adam Sun as Acting Chief Financial Officer
9. Ambry Genetics Announces Launch of Their CancerArray™ Product and Services Utilizing aCGH Technology
10. ORTHOCON Announces Signing of Exclusive, Worldwide License Agreement With Bezwada Biomedical
11. Caliper Life Sciences Announces IVIS Spectrum CT
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/31/2016)... May 31, 2016 ... Assembly zur Eliminierung von viraler Hepatitis    ... historische Verpflichtung eingegangen, virale Hepatitis bis 2030 zu ... World Health Assembly haben sich die Staaten einstimmig ... Hepatitis (Global Viral Hepatitis Strategy) zu verabschieden, was ...
(Date:5/30/2016)... York , May 30, 2016 ... report titled, "Advanced (3D/4D) Visualization Systems Market - Global ... - 2024." According to the report, the global advanced ... Bn in 2015 and is anticipated to expand at ... reach US$ 3.2 Bn in 2024. Advanced ...
(Date:5/30/2016)... , May 30, 2016 ... "Healthcare Analytical Testing Services Market by Type (Stability, ... Services), by End User (Pharmaceutical Companies, Medical Device ... MarketsandMarkets, The market witnessed healthy growth during the ... a CAGR of 11.3% between 2016 and 2021 ...
Breaking Medicine Technology:
(Date:5/31/2016)... ... May 31, 2016 , ... More than 80 representatives of the Hepatitis ... Prevent Cancer Foundation held an event on National Hepatitis Testing Day outside of Philadelphia ... hepatitis, the leading cause of liver cancer. , Foundation leaders and the citywide coalition ...
(Date:5/31/2016)... ... May 31, 2016 , ... ... mix of advanced Artificial Intelligence (AI) and the latest in Clinical Patient ... center is integrating predictive analytic outputs directly into the clinical workflow. These insights ...
(Date:5/31/2016)... Newport Beach, Calif. (PRWEB) , ... May 31, 2016 , ... ... trust among colleagues, clients, and the industry as a whole. On June 2, Northbound ... Coast Symposium on Addictive Disorders (WCSAD) and presenting the opening plenary on “Leadership: The ...
(Date:5/31/2016)... , ... May 31, 2016 , ... ... and numeral energies can describe personality traits in humans. Using presidential candidate Donald ... their name and vitality. , “AstroNumerology is not about adding numbers up,” ...
(Date:5/31/2016)... ... 31, 2016 , ... TeaZa® Energy, LLC announces the launch of ... No Tobacco Day . The new flavor—Tropical TeaZa? Energy—will be available to customers ... , The new flavor is best described as a juicy, taste bud takeover. ...
Breaking Medicine News(10 mins):